Abstract
The ability of cancer cells to produce and to respond to their own growth factors (autocrine secretion) has become a central concept linking oncogene and growth factor research. Oncogenes confer growth factor autonomy on cells not only by coding directly for autocrine peptide growth factors or their receptors, but also by amplifying the mitogenic signals generated by a growth factor at its receptor. Antagonists of positive autocrine growth factors can inhibit growth of cancer cells in experimental animals. Recently identified negative autocrine growth factors might themselves control aberrant cell growth.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Doolittle, R. F. et al. Science 221, 275–277 (1983).
Waterfield, M. D. et al. Nature 304, 35–39 (1983).
Downward, J. et al. Nature 307, 521–527 (1984).
Holley, R. W. Nature 258, 487–490 (1975).
Todaro, G. J. & De Larco, J. E. Cancer Res. 38, 4147–4154 (1978).
Sporn, M. B. & Todaro, G. J. New Engl. J. Med. 303, 878–880 (1980).
De Larco, J. E. & Todaro, G. J. Proc. natn. Acad. Sci. U.S.A. 75, 4001–4005 (1978).
Ozanne, B., Fulton, R. J. & Kaplan, P. L. J. Cell. Physiol. 105, 163–180 (1980).
Roberts, A. B., Frolik, C. A., Anzano, M. A. & Sporn, M. B. Fedn Proc. 42, 2621–2626 (1983).
Todaro, G. J., Fryling, C. & De Larco, J. E. Proc. natn. Acad. Sci. U.S.A. 77, 5258–5262 (1980).
Marquardt, H. & Todaro, G. J. J. biol. Chem. 257, 5220–5225 (1982).
Halper, J. & Moses, H. L. Cancer Res. 43, 1972–1979 (1983).
Richmond, A., Lawson, D. H., Nixon, D. W., Stevens, J. S. & Chawla, R. K. Cancer Res. 43, 2106–2112 (1983).
De Larco, J. E., Preston, Y. A. & Todaro, G. J. J. cell. Physiol. 109, 143–152 (1981).
Kaplan, P. L., Anderson, M. & Ozanne, B. Proc. natn. Acad. Sci. U.S.A. 79, 485–489 (1982).
Derynck, R., Roberts, A. B., Winkler, M. E., Chen, E. Y. & Goeddel, D. V. Cell 38, 287–297 (1984).
Lee, D. C., Rose, T. M., Webb, N. R. & Todaro, G. J. Nature 313, 489–491 (1985).
Anzano, M. A. et al. Molec. cell. Biol. 5, 242–247 (1985).
Bowen-Pope, D. F., Vogel, A. & Ross, R. Proc. natn. Acad. Sci. U.S.A. 81, 2396–2400 (1984).
Assoian, R. K., Grotendorst, G. R., Miller, D. M. & Sporn, M. B. Nature 309, 804–806 (1984).
Devare, S. G., Reddy, E. P., Law, J. D., Robbins, K. C. & Aaronson, S. A. Proc. natn. Acad. Sci. U.S.A. 80, 731–735 (1983).
Johnsson, A. et al. EMBO J. 3, 921–928 (1984).
Heldin, C., Westermark, B. & Wasteson, A. J. cell. Physiol. 105, 235–246 (1980).
Graves, D. T., Owen, A. J. & Antoniades, H. N. Cancer Res. 43, 83–87 (1983).
Nister, M., Heldin, C., Wasteson, A. & Westermark, B. Proc. natn. Acad. Sci. U.S.A. 81, 926–930 (1984).
Dicker, P., Pohjanpelto, P., Pettican, P. & Rozengurt, E. Expl Cell Res. 135, 221–227 (1981).
Owen, A. J., Pantazis, P. & Antoniades, H. N. Science 225, 54–56 (1984).
Huang, J. S., Huang, S. S. & Deuel, T. F. Cell 39, 79–87 (1984).
Seifert, R. A., Schwartz, S. M. & Bowen-Pope, D. F. Nature 311, 669–671 (1984).
Walker, L. N., Bowen-Pope, D. F. & Reidy, M. A. J. Cell Biol. 99, 416a (1984).
Cuttitta, F. et al. Nature (submitted).
Moody, T. W., Pert, C. B., Gazdar, A. F., Carney, D. N. & Minna, J. D. Science 214, 1246–1248 (1981).
Sorenson, G. D. et al. Regulat. Peptides 4, 59–66 (1982).
Erisman, M. D., Linnoila, R. I., Hernandez, O., DiAugustine, R. P. & Lazarus, L. H. Proc. natn. Acad. Sci. U.S.A. 79, 2379–2383 (1982).
Moody, T. W., Bertness, V. & Carney, D. N. Peptides 4, 683–686 (1983).
Rozengurt, E. & Sinnett-Smith, J. Proc. natn. Acad. Sci. U.S.A. 80, 2936–2940 (1983).
Carney, D. N. et al. Clin. Res. 31, 404A (1983).
Cowley, G., Smith, J. A., Gusterson, B., Hendler, F. & Ozanne, B. Cancer Cells 1, 5–10 (1984).
Haigler, H., Ash, J. F., Singer, S. J. & Cohen, S. Proc. natn. Acad. Sci. U.S.A. 75, 3317–3321 (1978).
Kawamoto, T. et al. Proc. natn. Acad. Sci. U.S.A. 80, 1337–1341 (1983).
Gregoriou, M. & Rees, A. R. EMBO J. 3, 929–937 (1984).
Masui, H. et al. Cancer Res. 44, 1002–1007 (1984).
Gallo, R. C. & Wong-Staal, F. Blood 60, 545–557 (1982).
Yodoi, J., Uchiyama, T. & Maeda, M. Blood 62, 509–510 (1983).
Waldmann, T. A. et al. J. clin. Invest. 73, 1711–1718 (1984).
Arya, S. K., Wong-Staal, F. & Gallo, R. C. Science 223, 1086–1087 (1984).
Bishop, J. M. A. Rev. Biochem. 52, 301–354 (1983).
Heldin, C. H., Ek, B. & Ronnstrand, L. J. biol. Chem. 258, 10054–10061 (1983).
Kasuga, M., Fujita-Yamaguchi, Y., Blithe, D. L., White, M. F. & Kahn, C. R. J. biol. Chem. 258, 10973–10980 (1983).
Rubin, J. B., Shia, M. A. & Plitch, P. R. Nature 305, 438–440 (1983).
Willingham, M. C., Pastan, I., Shih, T. Y. & Scolnick, E. M. Cell 19, 1005–1014 (1980).
Furth, M. E., Davis, L. J., Fleurdelys, B. & Scolnick, E. M. J. Virol. 43, 294–304 (1982).
Shih, T. Y., Papageorge, A. G., Stokes, P. E., Weeks, M. O. & Scolnick, E. M. Nature 287, 686–691 (1980).
McGrath, J. P., Capon, D. J., Goeddel, D. V. & Levinson, A. D. Nature 310, 644–649 (1984).
Sweet, R. W. et al. Nature 311, 273–275 (1984).
Hurley, J. B., Simon, M. I., Teplow, D. B., Robishaw, J. D. & Gilman, A. G. Science 226, 860–862 (1984).
Kamata, T. & Feramisco, J. R. Nature 310, 147–150 (1984).
Curran, T., Miller, D. A., Zokas, L. & Verma, I. M. Cell 36, 259–268 (1984).
Hann, S. R., Abrams, H. D., Rohrschneider, L. R. & Eisenman, R. N. Cell 34, 789–798 (1983).
Persson, H. & Leder, P. Science 225, 718–721 (1984).
Klempnauer, K., Symonds, G., Evan, G. I. & Bishop, J. M. Cell 37, 537–547 (1984).
Kelly, K., Cochran, B. H., Stiles, C. D. & Leder, P. Cell 35, 603–610 (1983).
Greenberg, M. E. & Ziff, E. B. Nature 311, 433–438 (1984).
Campisi, J., Gray, H. E., Pardee, A. B., Dean, M. & Sonenshein, G. E. Cell 36, 241–247 (1984).
Müller, R., Verma, I. M. & Adamson, E. D. EMBOJ. 2, 679–684 (1983).
Gonda, T. J. & Metcalf, D. Nature 310, 249–251 (1984).
Müller, R. & Wagner, E. F. Nature 311, 438–442 (1984).
Cochran, B. H., Zullo, J., Verma, I. M. & Stiles, C. D. 226, 1080–1082 (1984).
Stiles, C. D. et al. Proc. natn. Acad. Sci. U.S.A. 76, 1279–1283 (1979).
Armelin, H. A. et al. Nature 310, 655–660 (1984).
Roberts, A. B. et al. Proc. natn. Acad. Sci. U.S.A. 82, 119–123 (1985).
Holley, R. W. et al. Proc. natn. Acad. Sci. U.S.A. 77, 5989–5992 (1980).
Tucker, R. F., Shipley, G. D., Moses, H. L. & Holley, R. W. Science. 226, 705–707 (1984).
Tucker, R. F., Branum, E. L., Shipley, G. D., Ryan, R. J. & Moses, H. L. Proc. natn. Acad. Sci. U.S.A. 81, 6757–6761 (1984).
Assoian, R. K., Komoriya, A., Meyers, C. A., Miller, D. M. & Sporn, M. B. J. biol. Chem. 258, 7155–7160 (1983).
Frolik, C. A., Dart, L. L., Meyers, C. A., Smith, D. M. & Sporn, M. B. Proc. natn. Acad. Sci. U.S.A. 80, 3676–3680 (1983).
Roberts, A. B. et al. Biochemistry 22, 5692–5698 (1983).
Bullough, W. S. Cancer Res. 25, 1683–1727 (1965).
Potter, V. R. Prog. Nucleic Acid Res. molec. Biol. 29, 161–173 (1983).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sporn, M., Roberts, A. Autocrine growth factors and cancer. Nature 313, 745–747 (1985). https://doi.org/10.1038/313745a0
Issue Date:
DOI: https://doi.org/10.1038/313745a0
This article is cited by
-
Antitumour immunity regulated by aberrant ERBB family signalling
Nature Reviews Cancer (2021)
-
Signalling architectures can prevent cancer evolution
Scientific Reports (2020)
-
Secretome analysis of patient-derived GBM tumor spheres identifies midkine as a potent therapeutic target
Experimental & Molecular Medicine (2019)
-
Co-expression of ILT4/HLA-G in human non-small cell lung cancer correlates with poor prognosis and ILT4-HLA-G interaction activates ERK signaling
Tumor Biology (2016)
-
A model to explain specific cellular communications and cellular harmony:- a hypothesis of coupled cells and interactive coupling molecules
Theoretical Biology and Medical Modelling (2014)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.